91社区

Jason Karamchandani, MD

Jason Karamchandani, MD
Contact Information
Email address: 
jason.karamchandani [at] mcgill.ca
Hospital title: 
Associate Professor in the Department of Pathology
Neuropathologist
Biography: 

Dr. Jason Karamchandani is an Associate听Professor in the Department of Pathology, and is a neuropathologist at The Montreal Neurological Institute and Hospital. His clinical specialty is neuropathology and anatomic pathology. His research employs bio-informatic data to identify and to characterize biomarkers relevant to classification and prognosis of brain tumours and neuromuscular disorders. His laboratory at the Neuro will examine pathologies of both the central nervous system as well as neuromuscular disease.

Dr. Karamchandani also serves as the director of immunohistochemistry and special stains for the MUHC, program director for the 91社区 Anatomic Pathology residency program, and on the tissue and bio-banking committee of the MUHC research ethics board.

A graduate of Harvard University, where he received his AB Honours degree in biochemistry cum laude, Dr. Karamchandani earned his medical degree at Stanford University School of Medicine where he was class valedictorian. At Stanford, he pursued residency training in anatomic pathology, as well as fellowship training in surgical pathology and neuropathology.

Among his scientific achievements, Dr. Karamchandani has authored or co-authored 40 publications in peer-reviewed journals. He has published three book chapters, with the most recent describing the molecular alterations and clinical tests in tumours of the central nervous system, and tumours of the spinal cord.

Research areas: 
Rare Neurological Diseases

The Neuro logo91社区 logo

The Neuro (Montreal Neurological Institute-Hospital)听is a bilingual academic healthcare institution. We are a听91社区 research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the 91社区 Health Centre.听We are听proud to be a Killam Institution, supported by the Killam Trusts.

Back to top